Theacrine shows suppressive effects on TGF-β-induced progression and breast cancer cell metastasis by reversing EMT, which in turn leads to the downregulation of mesenchymal markers and upregulation of epithelial markers, and also attenuating TGF-β-induced EMT, cell adhesion, migration, and invasion. Here, TGFB1 is linked to breast carcinoma.